These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 11416621)

  • 41. Target Organ Damage in Hypertension.
    Odama U; Bakris G
    J Clin Hypertens (Greenwich); 2000 Oct; 2(5):312-318. PubMed ID: 11416667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Role of Multiple Drug Therapy for Controlling Hypertension in African Americans.
    Weir MR
    J Clin Hypertens (Greenwich); 2000 Mar; 2(2):99-108. PubMed ID: 11416633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are current strategies for treating hypertension effective?
    Sica DA
    J Clin Hypertens (Greenwich); 2003; 5(3 Suppl 2):23-32. PubMed ID: 12826767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease.
    Weir MR
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):100S-105S. PubMed ID: 15837552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcium channel blockers in hypertension. Is there still a controversy?
    Izzo JL
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):1-5. PubMed ID: 16640168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Applying hypertension guidelines to reduce the burden of heart failure.
    Baliga RR
    Cardiol Clin; 2007 Nov; 25(4):507-22; v-vi. PubMed ID: 18063156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implications of the ADVANCE study for clinical practice.
    Zannad F
    J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. From hypertension to heart failure -- are there better primary prevention strategies?
    Meredith PA; Ostergren J
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):64-73. PubMed ID: 17083060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
    Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA
    Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Missed Opportunity: Our Failure to Control Hypertension Optimally.
    Gifford RW
    J Clin Hypertens (Greenwich); 2000 Jan; 2(1):21-24. PubMed ID: 11416621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.